Literature DB >> 13167047

Cardiac emergencies.

D WHEATLEY.   

Abstract

Keywords:  ANTICOAGULANTS/therapeutic use; CONGESTIVE HEART FAILURE/therapy; CORONARY DISEASE/therapy

Mesh:

Substances:

Year:  1954        PMID: 13167047      PMCID: PMC1918862     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  13 in total

1.  Actions and uses of methorphinan.

Authors:  A J GLAZEBROOK
Journal:  Br Med J       Date:  1952-12-20

2.  Clinical trial of phenylindanedione as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1953-03-21

3.  [Therapy of pulmonary edema with procaine block of the right stellate ganglion].

Authors:  A PIERACH; K STOTZ
Journal:  Dtsch Med Wochenschr       Date:  1952-10-31       Impact factor: 0.628

4.  Study of antifoaming agents and preliminary evaluation of their use in experimental pulmonary edema.

Authors:  M B ROSENBLUTH; F H EPSTEIN; D J FELDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1952 Aug-Sep

5.  1-Arterenol (levophed) in the treatment of shock due to acute myocardial infarction.

Authors:  A J MILLER; L A BAKER
Journal:  AMA Arch Intern Med       Date:  1952-04

6.  Relief of acute left ventricular failure by priscol.

Authors:  D WHEATLEY
Journal:  Br Med J       Date:  1952-05-31

7.  The effect of norepinephrine upon pulmonary arteriolar resistance in man.

Authors:  N O FOWLER; R N WESTCOTT; R C SCOTT; J McGUIRE
Journal:  J Clin Invest       Date:  1951-05       Impact factor: 14.808

8.  The effect of epinephrine on the pulmonary circulation in man.

Authors:  A C WITHAM; J W FLEMING
Journal:  J Clin Invest       Date:  1951-07       Impact factor: 14.808

9.  Shock accompanying myocardial infarction: treatment with pressor amines amines.

Authors:  H K HELLERSTEIN; B L BROFMAN; W H CASKEY
Journal:  Am Heart J       Date:  1952-09       Impact factor: 4.749

10.  Comparison of vasoactive drugs in man.

Authors:  P R BROMAGE
Journal:  Br Med J       Date:  1952-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.